Company news
Procept Biorobotics Corporation (NASDAQ:PRCT) news
Procept Biorobotics Corporation news releases on 6ix. Latest, Feb 27, 2024: PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results
Press releases — page 2
PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results
February 26, 2024
PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston
February 11, 2024
PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million
January 7, 2024
PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City
November 12, 2023
PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
October 31, 2023
PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023
October 15, 2023
The National Institute for Health and Care Excellence Endorses Aquablation® Therapy with "Standard Arrangements" Recommendation
October 11, 2023
PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose
September 19, 2023
PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer
September 11, 2023
PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan
August 21, 2023
PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston
August 16, 2023
PROCEPT BioRobotics Corporation Announces Pricing of Upsized Offering of Common Stock
July 31, 2023
PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
July 26, 2023
PROCEPT BioRobotics to Report Second Quarter 2023 Financial Results on July 27, 2023
July 10, 2023
Five-Year Data from the WATER II Study Demonstrate Aquablation Therapy Delivers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms while Preserving Sexual Function in Men with Large Prostates
April 27, 2023
PROCEPT BioRobotics Reports First Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
April 26, 2023
PROCEPT BioRobotics to Report First Quarter 2023 Financial Results on April 27, 2023 and Present at the Bank of America 2023 Health Care Conference in Las Vegas
April 4, 2023
PROCEPT BioRobotics Corp. Announces United Healthcare Coverage of Aquablation Therapy for Men with Enlarged Prostates
April 2, 2023
PROCEPT BioRobotics Corp. Announces Investor Event at 2023 AUA Annual Meeting in Chicago
March 29, 2023
Aquablation Therapy is the first surgical robotics system to receive a MedTech Innovation Briefing (MIB) from the National Institute for Health Care Excellence
March 6, 2023
PROCEPT BioRobotics Corp. to Present at the Virtual Key Bank Life Sciences & MedTech Investor Forum
March 1, 2023
PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2022 Results
February 27, 2023
PROCEPT BioRobotics Corp. to Present at the 43rd Annual Cowen Health Care Conference in Boston
February 12, 2023
PROCEPT BioRobotics Announces Preliminary Fourth Quarter and Fiscal Year 2022 Revenue
January 8, 2023
PROCEPT BioRobotics Corp. to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 13, 2022
PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
November 2, 2022
PROCEPT BioRobotics to Report Third Quarter 2022 Financial Results on November 3, 2022
October 11, 2022
PROCEPT BioRobotics Announces $52 Million Debt Refinancing
October 9, 2022
PROCEPT BioRobotics Corp. to Present at 2022 Wells Fargo Healthcare Conference
August 21, 2022
PROCEPT BioRobotics Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
August 3, 2022
PROCEPT BioRobotics to Report Second Quarter 2022 Financial Results on August 4, 2022
July 13, 2022
PROCEPT BioRobotics Corporation Announces Additional Positive Coverage Policies Regarding Aquablation Therapy for Men with Enlarged Prostates
June 8, 2022
PROCEPT BioRobotics Reports First Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
May 4, 2022
PROCEPT BioRobotics Corporation Announces Aetna and Independence Blue Cross Blue Shield Positive Coverage Decisions Regarding Aquablation Therapy for Men with Enlarged Prostates
April 27, 2022
PROCEPT BioRobotics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022 and attend the 2022 Bank of America Healthcare Conference on May 11, 2022
April 11, 2022
PROCEPT BioRobotics Corp. Announces Investor Event at 2022 AUA Annual Meeting in New Orleans
April 10, 2022
PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2021 Financial Results
March 7, 2022
PROCEPT BioRobotics Corp. to Report Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022
February 21, 2022
PROCEPT Announces 5-Year WATER Study Data Comparing Aquablation to TURP
February 13, 2022
PROCEPT BioRobotics Corp. to Present at 11th Annual SVB Leerink Global Healthcare Conference and Cowen’s 42nd Annual Health Care Conference
January 31, 2022
Northside Healthcare System in Atlanta Advances Surgical Robotics Program with Multi-System, Multi-Hospital Agreement for PROCEPT BioRobotics AquaBeam Systems
January 17, 2022
PROCEPT BioRobotics Corp. Announces Preliminary Fourth Quarter and Fiscal Year 2021 Revenue
January 10, 2022
PROCEPT BioRobotics Appoints Mary Garrett to Board of Directors
January 3, 2022
PROCEPT BioRobotics Corp. Reports Third Quarter 2021 Financial Results and Provides 2021 Revenue Guidance
November 3, 2021
PROCEPT BioRobotics Appoints Elisabeth Sandoval to Board of Directors
October 25, 2021
PROCEPT BioRobotics Corp. to Report Third Quarter 2021 Financial Results on November 4, 2021
October 20, 2021
PROCEPT BioRobotics Corporation Announces Cigna Adds Aquablation Therapy to its Coverage Policy
September 27, 2021
PROCEPT BioRobotics Corporation Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
September 20, 2021
PROCEPT BioRobotics Corporation Announces Pricing of Upsized Initial Public Offering
September 13, 2021